LIFECORE BIOMEDICAL, INC. Accounts Receivable, Related Parties, Current
LIFECORE BIOMEDICAL, INC. (LFCR) had Accounts Receivable, Related Parties, Current of $150.00 thousand as of 2017-02-26, per its 10-Q filed 2017-04-07.
Discontinued › Notes › Receivables
us-gaap:AccountsReceivableRelatedPartiesCurrent · last filed 2017-04-07
- 2017-02-26: Accounts Receivable, Related Parties, Current $150.00K.
- 2016-11-27: Accounts Receivable, Related Parties, Current $183.00K.
- 2016-08-28: Accounts Receivable, Related Parties, Current $351.00K.
- 2016-05-29: Accounts Receivable, Related Parties, Current $523.00K.
| Period end | Accounts Receivable, Related Parties, Current | Accounts Receivable, Related Parties, Current as first filed |
|---|---|---|
| 2017-02-26 | $150.00K 10-Q · filed 2017-04-07 | |
| 2016-11-27 | $183.00K 10-Q · filed 2017-01-05 | |
| 2016-08-28 | $351.00K 10-Q · filed 2016-09-29 | |
| 2016-05-29 | $523.00K 10-Q · filed 2017-01-05 | |
| 2016-02-28 | $523.00K 10-Q · filed 2017-04-07 | |
| 2015-05-31 | $306.00K 10-K · filed 2015-07-31 | |
| 2015-03-01 | $35.00K 10-Q · filed 2015-04-02 | |
| 2014-11-30 | $162.00K 10-Q · filed 2015-01-09 | |
| 2014-08-31 | $338.00K 10-Q · filed 2014-10-08 | |
| 2014-05-25 | $304.00K 10-K · filed 2015-07-31 | |
| 2014-02-23 | $189.00K 10-Q · filed 2014-03-28 | |
| 2013-11-24 | $131.00K 10-Q · filed 2014-01-03 | |
| 2013-08-25 | $205.00K 10-Q · filed 2013-09-26 | |
| 2013-05-26 | $316.00K 10-K · filed 2014-08-01 | $671.00K 10-K · filed 2013-08-07 |
| 2013-02-24 | $312.00K 10-Q · filed 2013-04-04 | |
| 2012-11-25 | $313.00K 10-Q · filed 2013-01-04 | |
| 2012-08-26 | $268.00K 10-Q/A · filed 2013-01-02 | |
| 2012-05-27 | $323.00K 10-K · filed 2013-08-07 | |
| 2012-02-26 | $378.00K 10-Q · filed 2012-03-28 | |
| 2011-11-27 | $314.00K 10-Q · filed 2012-01-05 | |
| 2011-08-28 | $413.00K 10-Q · filed 2011-10-05 | |
| 2011-05-29 | $453.00K 10-K · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |